Suppliers · Producer · Discovered — similar established company

Rev Genomics

We are an Oakland, California, plant biotechnology company utilizing cutting edge breeding tools for high-value crops. Our toolkit includes whole genome selection, advanced tissue culture, molecular genetics and in-house metabolite analytics. We are backed by Y-Combinator and our platform has been featured in TechCrunch.

active United StatesUSA & Canada Founded 2015 UnlistedEmployees: 5-8 Revenue: $2,000,000 USD (2026) checked 2026-10-05

Profile

Industry: Seeds & genetics
Topics: Hybrid seeds & crop breeding, GM traits & gene editing
Role: Producer — “…: - Genomics Data Pipeline: processes large sequencing datasets to guide efficient, rational phenotype design,…”
Why it is bioeconomy: Rev Genomics is a plant biotechnology company that develops and licenses high-value crop cultivars using genomic breeding, tissue culture, and data science.
Found via: Pairwise; Inari Agriculture

Bio-solutions it supplies 0

Not yet cited as a supplier in a graded solution.

What they offer

This company does not publish its products or services — we find out through an introduction.

News & status 6

2025-10-09 RevGenetics Celebrates FDA's Landmark Reversal on NMN, Affirming Its Status as a Lawful Dietary Supplement
RevGenetics is presented as a pioneering and advocating force behind NMN's lawful status as a dietary supplement after the FDA reversed its stance, citing the company’s early NMN marketing and evidence (including a 2014 sale) as influential. The piece …
2026-02-17 Revvity launches somatic cancer reference standards - CAP TODAY
Revvity is expanding its somatic cancer reference standards, leveraging collaboration with MDIC and NIST to create Mimix Geni reference standards (based on Genome in a Bottle cell lines) containing seven clinically significant oncogenic mutations, with …
2026-06-09 Alithea Genomics and Revvity Announce Distribution Agreement to Expand Access to MERCURIUSTM DRUG-seq Solutions
Rev Genomics (Revvity) is expanding its drug-discovery portfolio by adding MERCURIUS DRUG-seq and MERCURIUS Total DRUG-seq from Alithea Genomics, enabling scalable transcriptomic profiling to enhance phenotypic and functional genomics workflows and support …
2026-08-05 RevaGenix secures $12.1 million NIAID contract for antimicrobial-resistant infection therapeutics
RevaGenix, a San Mateo biotech, has secured a $12.1 million NIAID R&D contract to advance antimicrobial-resistant infection therapeutics through early clinical development, including lead optimization and IND-enabling work, highlighting government support for …
2026-05-01 Cloud Native Platform for Molecular Cloning Workflows
Summary: Revvity’s Signals BioDesign is a cloud-based platform for molecular cloning that consolidates construct design, sequencing analysis, and various workflows (Golden Gate, Gibson, restriction/ligation, primer design, Sanger analysis, protein translation) …
2026-07-21 Revvity Creates Program to Equip Young Biotechs with Scalable Informatics Capabilities Sooner than Later
Revvity is launching Signals for Startups, a program within its Signals Software unit that provides early-stage biotechs with scalable informatics, guided onboarding, and pre-configured workflows to accelerate discovery, standardize data, and speed …

Network: owners, partners, peers

Ownership & investors 3

parent	Merida Capital Holdings
investor	Y Combinator
investor	Merida Capital Partners

Similar companies

Pairwise · NuCicer · Verinomics · Front Range Biosciences · Terrana Biosciences · Avalo, Inc. · KeyGene · InnerPlant

Identity & contacts

Contacts, people and legal identity are available to members.